{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:06:36Z","timestamp":1789387596567,"version":"build-2803163510"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"publisher","award":["12518"],"award-info":[{"award-number":["12518"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>In node-positive (cN+) breast cancer treated with neoadjuvant systemic therapy, combining sentinel lymph node biopsy and targeted lymph node excision, that is targeted axillary dissection, increases accuracy. Targeted axillary dissection procedures differ in terms of the targeted lymph node excision technique. This systematic review aimed to provide an overview of targeted axillary dissection procedures regarding definitive marker type and timing of placement: before neoadjuvant systemic therapy (1-step procedure) or after neoadjuvant systemic therapy adjacent to a clip placed before the neoadjuvant therapy (2-step procedure).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>PubMed and Embase were searched, to 4 July 2023, for RCTs, cohort studies, and case\u2013control studies with at least 25 patients. Studies of targeted lymph node excision only (without sentinel lymph node biopsy), or where intraoperative localization of the targeted lymph node was not attempted, were excluded. For qualitative synthesis, studies were grouped by definitive marker and timing of placement. The targeted lymph node identification rate was reported. Study quality was assessed using a National Institutes of Health quality assessment tool.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Of 277 unique records, 51 studies with a total of 4512 patients were included. Six definitive markers were identified: wire, 125I-labelled seed, 99mTc, (electro)magnetic\/radiofrequency markers, black ink, and a clip. Fifteen studies evaluated one-step procedures, with the identification rate of the targeted lymph node at surgery varying from 8 of 13 to 47 of 47. Forty-one studies evaluated two-step procedures, with the identification rate of the clipped targeted lymph node on imaging after neoadjuvant systemic therapy varying from 49 to 100%, and the identification rate of the targeted lymph node at surgery from 17 of 24 to 100%. Most studies (40 of 51) were rated as being of fair quality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Various targeted axillary dissection procedures are used in clinical practice. Owing to study heterogeneity, the optimal targeted lymph node excision technique in terms of identification rate and feasibility could not be determined. Two-step procedures are at risk of not identifying the clipped targeted lymph node on imaging after neoadjuvant systemic therapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/bjs\/znae071","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T01:32:20Z","timestamp":1711503140000},"source":"Crossref","is-referenced-by-count":35,"title":["Systematic review of targeted axillary dissection in node-positive breast cancer treated with neoadjuvant systemic therapy: variation in type of marker and timing of placement"],"prefix":"10.1093","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6110-2308","authenticated-orcid":false,"given":"Sabine R","family":"de Wild","sequence":"first","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Centre+, GROW School for Oncology and Reproduction , Maastricht , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linetta B","family":"Koppert","sequence":"additional","affiliation":[{"name":"Department of Surgery, Erasmus Medical Centre , Rotterdam , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiemo J A","family":"van Nijnatten","sequence":"additional","affiliation":[{"name":"Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, GROW School for Oncology and Reproduction , Maastricht , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loes F S","family":"Kooreman","sequence":"additional","affiliation":[{"name":"Department of Pathology, Maastricht University Medical Centre+, GROW School for Oncology and Reproduction , Maastricht , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Jeanne T F D","family":"Vrancken Peeters","sequence":"additional","affiliation":[{"name":"Department of Surgery, Netherlands Cancer Institute , Amsterdam , the Netherlands"},{"name":"Department of Surgery, Amsterdam University Medical Centre , Amsterdam , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein L","family":"Smidt","sequence":"additional","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Centre+, GROW School for Oncology and Reproduction , Maastricht , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janine M","family":"Simons","sequence":"additional","affiliation":[{"name":"Department of Surgery, Maastricht University Medical Centre+, GROW School for Oncology and Reproduction , Maastricht , the Netherlands"},{"name":"Department of Radiotherapy, Erasmus Medical Centre , Rotterdam , the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"2024032909470212900_znae071-B1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2024032909470212900_znae071-B2","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.07.4062","article-title":"Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial Z0011","volume":"25","author":"Lucci","year":"2007","journal-title":"J Clin Oncol"},{"key":"2024032909470212900_znae071-B3","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (alliance) prospective multicenter clinical trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"key":"2024032909470212900_znae071-B4","doi-asserted-by":"crossref","first-page":"e210891","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"key":"2024032909470212900_znae071-B5","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"key":"2024032909470212900_znae071-B6","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","article-title":"Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis","volume":"269","author":"Simons","year":"2019","journal-title":"Ann Surg"},{"key":"2024032909470212900_znae071-B7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"key":"2024032909470212900_znae071-B8","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1200\/JCO.2011.38.8595","article-title":"Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes","volume":"30","author":"von Minckwitz","year":"2012","journal-title":"J Clin Oncol"},{"key":"2024032909470212900_znae071-B9","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamaoncol.2015.4935","article-title":"Ten-year outcomes of patients with breast cancer with cytologically confirmed axillary lymph node metastases and pathologic complete response after primary systemic chemotherapy","volume":"2","author":"Mougalian","year":"2016","journal-title":"JAMA Oncol"},{"key":"2024032909470212900_znae071-B10","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/SLA.0000000000002953","article-title":"The clinical significance of breast-only and node-only pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT): a review of 20 000 breast cancer patients in the National Cancer Data Base (NCDB)","volume":"268","author":"Fayanju","year":"2018","journal-title":"Ann Surg"},{"key":"2024032909470212900_znae071-B11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"key":"2024032909470212900_znae071-B12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"key":"2024032909470212900_znae071-B13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"key":"2024032909470212900_znae071-B14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"key":"2024032909470212900_znae071-B15","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/bjs.7073","article-title":"Marking the axilla with radioactive iodine seeds (MARI procedure) may reduce the need for axillary dissection after neoadjuvant chemotherapy for breast cancer","volume":"97","author":"Straver","year":"2010","journal-title":"Br J Surg"},{"key":"2024032909470212900_znae071-B16","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/SLA.0000000000000558","article-title":"Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure","volume":"261","author":"Donker","year":"2015","journal-title":"Ann Surg"},{"key":"2024032909470212900_znae071-B17","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1200\/JCO.2015.64.0094","article-title":"Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection","volume":"34","author":"Caudle","year":"2016","journal-title":"J Clin Oncol"},{"key":"2024032909470212900_znae071-B18","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/SLA.0000000000001375","article-title":"Identification and resection of clipped node decreases the false-negative rate of sentinel lymph node surgery in patients presenting with node-positive breast cancer (T0\u2013T4, N1\u2013N2) who receive neoadjuvant chemotherapy: results from ACO SOG Z107 1 (Alliance)","volume":"263","author":"Boughey","year":"2016","journal-title":"Ann Surg"},{"key":"2024032909470212900_znae071-B19","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2022","journal-title":"Ann Surg"},{"key":"2024032909470212900_znae071-B20","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1245\/s10434-017-6270-z","article-title":"Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA trial) : a new tool to guide the excision of the clipped node after neoadjuvant treatment","volume":"25","author":"Siso","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B21","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/jamasurg.2022.3907","article-title":"Diagnostic accuracy of radioactive iodine seed placement in the axilla with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer","volume":"157","author":"Simons","year":"2022","journal-title":"JAMA Surg"},{"key":"2024032909470212900_znae071-B22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.ejso.2015.11.019","article-title":"Sentinel node biopsy after neoadjuvant treatment in breast cancer: five-year follow-up of patients with clinically node-negative or node-positive disease before treatment","volume":"42","author":"Galimberti","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"2024032909470212900_znae071-B23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s10549-022-06545-z","article-title":"Three-year follow-up of de-escalated axillary treatment after neoadjuvant systemic therapy in clinically node-positive breast cancer: the MARI-protocol","volume":"193","author":"van Loevezijn","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"2024032909470212900_znae071-B24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.breast.2022.12.010","article-title":"This house believes that: sentinel node biopsy alone is better than TAD after NACT for cN+ patients","volume":"67","author":"Galimberti","year":"2023","journal-title":"Breast"},{"key":"2024032909470212900_znae071-B25","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.breast.2021.03.008","article-title":"The applicability of Magseed\u00ae for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy","volume":"57","author":"Reitsamer","year":"2021","journal-title":"Breast"},{"key":"2024032909470212900_znae071-B26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.clbc.2019.01.013","article-title":"Axillary lymph node tattooing and targeted axillary dissection in breast cancer patients who presented as cN+ before neoadjuvant chemotherapy and became cN0 after treatment","volume":"19","author":"Natsiopoulos","year":"2019","journal-title":"Clin Breast Cancer"},{"key":"2024032909470212900_znae071-B27","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ejso.2019.12.007","article-title":"Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy","volume":"46","author":"Balasubramanian","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2024032909470212900_znae071-B28","author":"PRISMA"},{"key":"2024032909470212900_znae071-B29","author":"NIH"},{"key":"2024032909470212900_znae071-B30","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1245\/s10434-015-4527-y","article-title":"Improving the accuracy of axillary lymph node surgery in breast cancer with ultrasound-guided wire localization of biopsy proven metastatic lymph nodes","volume":"22","author":"Plecha","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B31","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.clinimag.2017.10.003","article-title":"Lymph node wire localization post-chemotherapy: towards improving the false negative sentinel lymph node biopsy rate in breast cancer patients","volume":"48","author":"Dashevsky","year":"2018","journal-title":"Clin Imaging"},{"key":"2024032909470212900_znae071-B32","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.ejso.2018.05.035","article-title":"Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy","volume":"44","author":"Hartmann","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"2024032909470212900_znae071-B33","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.surge.2021.01.013","article-title":"Sentinel lymph node BIOPSY after neoadjuvant therapy in breast cancer patients with lymph node involvement at diagnosis. Could wire localization of clipped node improve our results?","volume":"19","author":"Alarcon","year":"2021","journal-title":"Surgeon"},{"key":"2024032909470212900_znae071-B34","doi-asserted-by":"crossref","first-page":"101636","DOI":"10.1016\/j.suronc.2021.101636","article-title":"Feasibility and validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: definitive results","volume":"38","author":"Flores-Funes","year":"2021","journal-title":"Surg Oncol"},{"key":"2024032909470212900_znae071-B35","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1245\/s10434-020-08925-5","article-title":"Combining wire localization of clipped nodes with sentinel lymph node biopsy after neoadjuvant chemotherapy in node-positive breast cancer: preliminary results from a prospective study","volume":"28","author":"Garcia-Novoa","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4174\/astr.2021.100.6.305","article-title":"Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy","volume":"100","author":"Gurleyik","year":"2021","journal-title":"Ann Surg Treat Res"},{"key":"2024032909470212900_znae071-B37","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.31083\/j.ejgo4206186","article-title":"Evaluation of axillary response to neoadjuvant systemic therapy with sentinel node biopsy and axillary wire in node-positive breast cancer","volume":"42","author":"Sierra","year":"2021","journal-title":"Eur J Gynaecol Oncol"},{"key":"2024032909470212900_znae071-B38","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ciresp.2022.05.004","article-title":"Lymph node staging after primary systemic therapy in women with breast cancer and lymph node involvement at diagnosis","volume":"101","author":"Acea-Figueira","year":"2023","journal-title":"Cir Esp (Engl Ed)"},{"key":"2024032909470212900_znae071-B39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jso.27241","article-title":"Axillary lymph node recurrence following wire-directed sentinel lymph node dissection for breast cancer patients with biopsy-proven axillary metastases prior to neoadjuvant chemotherapy at a safety net medical center","volume":"128","author":"Sargent","year":"2023","journal-title":"J Surg Oncol"},{"key":"2024032909470212900_znae071-B40","first-page":"1863","article-title":"Clinical feasibility and oncological safety of non-radioactive targeted axillary dissection after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: a prospective diagnostic and prognostic study","volume":"109","author":"Wu","year":"2023","journal-title":"Int J Surg"},{"key":"2024032909470212900_znae071-B41","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1245\/s10434-023-13792-x","article-title":"Comparing methods for targeted axillary dissection in breast cancer patients: a nationwide, retrospective study","volume":"30","author":"Munck","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B42","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/bjs.11320","article-title":"Excision of both pretreatment marked positive nodes and sentinel nodes improves axillary staging after neoadjuvant systemic therapy in breast cancer","volume":"106","author":"Simons","year":"2019","journal-title":"Br J Surg"},{"key":"2024032909470212900_znae071-B43","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10549-021-06281-w","article-title":"Early reflector localization improves the accuracy of localization and excision of a previously positive axillary lymph node following neoadjuvant chemotherapy in patients with breast cancer","volume":"189","author":"Balija","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"2024032909470212900_znae071-B44","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1245\/s10434-015-5052-8","article-title":"Axillary staging after neoadjuvant chemotherapy for breast cancer: a pilot study combining sentinel lymph node biopsy with radioactive seed localization of pre-treatment positive axillary lymph nodes","volume":"23","author":"Diego","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B45","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1245\/s10434-017-6023-z","article-title":"Localizing the clipped node in patients with node-positive breast cancer treated with neoadjuvant chemotherapy: early learning experience and challenges","volume":"24","author":"Nguyen","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B46","first-page":"e14610","article-title":"Targeted axillary dissection in node-positive breast cancer: a retrospective study and cost analysis","volume":"13","author":"Beniey","year":"2021","journal-title":"Cureus"},{"key":"2024032909470212900_znae071-B47","doi-asserted-by":"crossref","first-page":"101823","DOI":"10.1016\/j.suronc.2022.101823","article-title":"Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer","volume":"44","author":"Aragon-Sanchez","year":"2022","journal-title":"Surg Oncol"},{"key":"2024032909470212900_znae071-B48","first-page":"71","article-title":"Radioguided surgery with iodine-125 seeds in breast cancer patients treated with neoadjuvant chemotherapy","volume":"41","author":"Rebollo Aguirre","year":"2022","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"2024032909470212900_znae071-B49","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1245\/s10434-022-11324-7","article-title":"How often does retrieval of a clipped lymph node change adjuvant therapy recommendations? A prospective, consecutive, patient cohort study","volume":"29","author":"Weiss","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B50","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10549-023-06983-3","article-title":"Response in axillary lymph nodes to neoadjuvant chemotherapy for breast cancers: correlation with breast response, pathologic features, and accuracy of radioactive seed localization","volume":"200","author":"Clark","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"2024032909470212900_znae071-B51","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1245\/s10434-023-13432-4","article-title":"Targeted axillary dissection with 125I seed placement before neoadjuvant chemotherapy in a Danish multicenter cohort","volume":"30","author":"Munck","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B52","first-page":"284","article-title":"Patients with initial nodal involvement due to breast cancer who have received neoadjuvant chemotherapy: combined sentinel node-radioguided surgery of the pathological node","volume":"41","author":"Fuertes Manuel","year":"2022","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"2024032909470212900_znae071-B53","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.ejso.2023.03.208","article-title":"Targeted axillary dissection using radioguided occult lesion localization technique in the clinically negative marked lymph node after neoadjuvant treatment in breast cancer patients","volume":"49","author":"Del Castillo","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"2024032909470212900_znae071-B54","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3390\/cancers15072046","article-title":"Selective axillary dissection after neoadjuvant chemotherapy in patients with lymph-node-positive breast cancer (CLYP study): the radio-guided occult lesion localization technique for biopsy-proven metastatic lymph nodes","volume":"15","author":"Rella","year":"2023","journal-title":"Cancers (Basel)"},{"key":"2024032909470212900_znae071-B55","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1111\/ans.18079","article-title":"Radio-isotope occult lesion localization (ROLL) techniques to identify the clipped node for targeted axillary dissection (TAD) in breast cancer","volume":"92","author":"Winder","year":"2022","journal-title":"ANZ J Surg"},{"key":"2024032909470212900_znae071-B56","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1097\/RLU.0000000000004669","article-title":"SPECT\/CT lymphoscintigraphy accurately localizes clipped and sentinel nodes after neoadjuvant chemotherapy in node-positive breast cancer","volume":"48","author":"Dilege","year":"2023","journal-title":"Clin Nucl Med"},{"key":"2024032909470212900_znae071-B57","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1245\/s10434-020-08902-y","article-title":"Node-positive patients treated with neoadjuvant chemotherapy can be spared axillary lymph node dissection with wireless non-radioactive localizers","volume":"27","author":"Laws","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B58","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.suronc.2020.11.013","article-title":"Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer","volume":"36","author":"Mariscal Martinez","year":"2021","journal-title":"Surg Oncol"},{"key":"2024032909470212900_znae071-B59","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.1245\/s10434-020-09542-y","article-title":"Prospective registry trial assessing the use of magnetic seeds to locate clipped nodes after neoadjuvant chemotherapy for breast cancer patients","volume":"28","author":"Simons","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B60","doi-asserted-by":"crossref","first-page":"6111907","DOI":"10.1155\/2022\/6111907","article-title":"Evaluation of axillary lymph node marking with Magseed\u00ae before and after neoadjuvant systemic therapy in breast cancer patients: MAGNET study","volume":"2022","author":"Martinez","year":"2022","journal-title":"Breast J"},{"key":"2024032909470212900_znae071-B61","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ejso.2022.12.019","article-title":"Clinical utility of axillary nodal markers in breast cancer","volume":"49","author":"Barry","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"2024032909470212900_znae071-B62","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1016\/j.clbc.2020.08.001","article-title":"Feasibility of axillary lymph node localization and excision using radar reflector localization","volume":"21","author":"Sun","year":"2020","journal-title":"Clin Breast Cancer"},{"key":"2024032909470212900_znae071-B63","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clinimag.2022.07.007","article-title":"Ultrasound-guided radar reflector localization of axillary lymph nodes facilitates targeted axillary dissection","volume":"90","author":"Weinfurtner","year":"2022","journal-title":"Clin Imaging"},{"key":"2024032909470212900_znae071-B64","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jss.2022.10.023","article-title":"Localizing positive axillary lymph nodes in breast cancer patients post neoadjuvant therapy","volume":"283","author":"Taj","year":"2023","journal-title":"J Surg Res"},{"key":"2024032909470212900_znae071-B65","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1186\/s12885-019-6095-1","article-title":"Ultrasound-guided dual-localization for axillary nodes before and after neoadjuvant chemotherapy with clip and activated charcoal in breast cancer patients: a feasibility study","volume":"19","author":"Kim","year":"2019","journal-title":"BMC Cancer"},{"key":"2024032909470212900_znae071-B66","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1245\/s10434-019-07419-3","article-title":"Pretreatment tattoo marking of suspicious axillary lymph nodes: reliability and correlation with sentinel lymph node","volume":"26","author":"Patel","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B67","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.ejso.2019.11.501","article-title":"Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery","volume":"46","author":"Allweis","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2024032909470212900_znae071-B68","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1159\/000514266","article-title":"Selective extirpation of tattooed lymph node in combination with sentinel lymph node biopsy in the management of node-positive breast cancer patients after neoadjuvant systemic therapy","volume":"16","author":"Dostalek","year":"2021","journal-title":"Breast Care (Basel)"},{"key":"2024032909470212900_znae071-B69","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10549-022-06588-2","article-title":"False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy","volume":"193","author":"de Boniface","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"2024032909470212900_znae071-B70","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000517208","article-title":"Targeted axillary dissection after chemotherapy: feasibility study with clip and carbon dye tattoo\u2014Neotarget trial","volume":"17","author":"Pinto","year":"2022","journal-title":"Breast Care (Basel)"},{"key":"2024032909470212900_znae071-B71","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/03008916221107712","article-title":"Carbon tattooing of axillary lymph nodes in breast cancer patients before neoadjuvant chemotherapy: a retrospective analysis","volume":"109","author":"Porpiglia","year":"2023","journal-title":"Tumori"},{"key":"2024032909470212900_znae071-B72","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/jso.25928","article-title":"Marking axillary nodes with 4% carbon microparticle suspension before neoadjuvant chemotherapy improves sentinel node identification rate and axillary staging","volume":"122","author":"Spautz","year":"2020","journal-title":"J Surg Oncol"},{"key":"2024032909470212900_znae071-B73","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s12282-022-01349-x","article-title":"Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients","volume":"29","author":"Pinto","year":"2022","journal-title":"Breast Cancer"},{"key":"2024032909470212900_znae071-B74","doi-asserted-by":"crossref","first-page":"106938","DOI":"10.1016\/j.ejso.2023.05.013","article-title":"Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment","volume":"49","author":"Siso","year":"2023","journal-title":"Eur J Surg Oncol"},{"key":"2024032909470212900_znae071-B75","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10549-020-05589-3","article-title":"De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study","volume":"180","author":"Simons","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"2024032909470212900_znae071-B76","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejso.2019.08.012","article-title":"Patterns of axillary staging and management in clinically node positive breast cancer patients treated with neoadjuvant systemic therapy: results of a survey amongst breast cancer specialists","volume":"46","author":"Simons","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"2024032909470212900_znae071-B77","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1245\/s10434-017-5958-4","article-title":"Use of sentinel lymph node dissection after neoadjuvant chemotherapy in patients with node-positive breast cancer at diagnosis: practice patterns of American Society of Breast Surgeons members","volume":"24","author":"Caudle","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B78","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1245\/s10434-018-6637-9","article-title":"Decreasing use of axillary dissection in node-positive breast cancer patients treated with neoadjuvant chemotherapy","volume":"25","author":"Nguyen","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"2024032909470212900_znae071-B79","doi-asserted-by":"crossref","first-page":"4167","DOI":"10.3390\/cancers13164167","article-title":"Options to determine pathological response of axillary lymph node metastasis after neoadjuvant chemotherapy in advanced breast cancer","volume":"13","author":"Murthy","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2024032909470212900_znae071-B80","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s10549-020-05707-1","article-title":"A comparison of two non-radioactive alternatives to wire for the localization of non-palpable breast cancers","volume":"182","author":"Lee","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"2024032909470212900_znae071-B81","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.rcl.2016.12.012","article-title":"Update on preoperative breast localization","volume":"55","author":"Hayes","year":"2017","journal-title":"Radiol Clin North Am"},{"key":"2024032909470212900_znae071-B82","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.3390\/medicina59101727","article-title":"The magnetic technique\u2014a novel and promising method to improve axillary staging localisation from a Swedish perspective","volume":"59","author":"W\u00e4rnberg","year":"2023","journal-title":"Medicina (B Aires)"},{"key":"2024032909470212900_znae071-B83","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/cancers13071565","article-title":"Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the EUBREAST-03 AXSANA study","volume":"13","author":"Banys-Paluchowski","year":"2021","journal-title":"Cancers (Basel)"},{"key":"2024032909470212900_znae071-B84","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1093\/jbi\/wbab082","article-title":"Axillary imaging following a new invasive breast cancer diagnosis\u2014a radiologist\u2019s dilemma","volume":"3","author":"Dialani","year":"2021","journal-title":"Journal of Breast Imaging"},{"key":"2024032909470212900_znae071-B85","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s10549-023-07100-0","article-title":"Applicability of magnetic seeds for target lymph node biopsy after neoadjuvant chemotherapy in initially node-positive breast cancer patients: data from the AXSANA study","volume":"202","author":"Hartmann","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"2024032909470212900_znae071-B86","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12957-023-03147-x","article-title":"Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial","volume":"21","author":"Zatecky","year":"2023","journal-title":"World J Surg Oncol"},{"key":"2024032909470212900_znae071-B87","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.clbc.2021.07.011","article-title":"MINImal vs. MAXimal invasive axillary staging and treatment after neoadjuvant systemic therapy in node positive breast cancer: protocol of a Dutch multicenter registry study (MINIMAX)","volume":"22","author":"de Wild","year":"2022","journal-title":"Clin Breast Cancer"}],"container-title":["British Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/111\/3\/znae071\/57117880\/znae071.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjs\/article-pdf\/111\/3\/znae071\/57117880\/znae071.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T09:47:52Z","timestamp":1711705672000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjs\/article\/doi\/10.1093\/bjs\/znae071\/7635427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":87,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,3,26]]},"published-print":{"date-parts":[[2024,3,2]]}},"URL":"https:\/\/doi.org\/10.1093\/bjs\/znae071","relation":{},"ISSN":["0007-1323","1365-2168"],"issn-type":[{"value":"0007-1323","type":"print"},{"value":"1365-2168","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,3]]},"published":{"date-parts":[[2024,3]]},"article-number":"znae071"}}